Condition (MeSH)
Sex Cord-Gonadal Stromal Tumors
ClinicalTrials.gov lists 15 trials for Sex Cord-Gonadal Stromal Tumors or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 15 trials are tagged with Sex Cord-Gonadal Stromal Tumors itself; the rest are tagged with a narrower condition beneath it.
When did Sex Cord-Gonadal Stromal Tumors trials start? (11)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 2 |
| 2019 | 1 |
| 2018 | 1 |
| 2016 | 1 |
| 2014 | 1 |
| 2012 | 3 |
| 2011 | 1 |
| 2010 | 2 |
| 2008 | 1 |
| 2005 | 1 |
Showing 10 of 11 earlier years.
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Sex Cord-Gonadal Stromal Tumors trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 8 |
| Not applicable | 2 |
| Observational | 4 |
How many Sex Cord-Gonadal Stromal Tumors trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Completed | 7 |
| Terminated | 2 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Sex Cord-Gonadal Stromal Tumors trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Children's Oncology Group | 1 |
| GOG Foundation | 1 |
| Gynecologic Oncology Group | 1 |
| National Cancer Institute (NCI) | 1 |
Which drugs are being tested for Sex Cord-Gonadal Stromal Tumors? (5)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| (nab)-paclitaxel | 2 |
| FULVESTRANT | 1 |
| NIVOLUMAB | 1 |
| Bleomycin | 1 |
| TAK-700 | 1 |
Interventions as named in the registry (7)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| or carboplatin | 2 |
| Gemcitabine/Gemzar | 1 |
| Cisplatin 1 | 1 |
| Stereotactic Body Radiation Therapy | 1 |
| Etoposid | 1 |
Showing 5 of 7 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Sex Cord-Gonadal Stromal Tumors trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Neutrophil Count Decreased | 12 | 1 |
| Hyperglycemia | 4 | 3 |
| Obstruction, Gi - Small Bowel Nos | 3 | 1 |
| Constipation | 2 | 1 |
| Febrile Neutropenia | 2 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Sex Cord-Gonadal Stromal Tumors? (13)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents. | Pediatric blood & cancer | 2021 | Yes |
| Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial. | JAMA oncology | 2020 | Yes |
| Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases. | The oncologist | 2018 | Yes |
| DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry. | Gynecologic oncology | 2017 | Yes |
| Ovarian Sex Cord-Stromal Tumors. | Journal of oncology practice | 2016 | Yes |
Showing 5 of 13 publications.
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.